“Treatment of Relapsed Refractory CLL With Venetoclax-Rituximab During the COVID-19 Pandemic: A Daily-Life Experience in Southern Italy”. 2021. Mediterranean Journal of Hematology and Infectious Diseases 13 (1): e2021042. https://doi.org/10.4084/MJHID.2021.042.